Akros SCHK HK-Global Genomics Index

Illumina is scheduled to announce its second quarter 2026 financial results after market close on July 30, 2026; earnings releases typically result in significant price volatility (estimated >5% impact), expected.

Illumina announced the appointment of Michael Sullivan as Chief Commercial Officer and Julie Coletti as Chief Legal Officer on July 9, 2026.